A nasal spray to treat life-threatening allergic reactions has been given the green light by US regulators. Anaphylaxis, a severe and potentially fatal allergic reaction, requires immediate treatment ...
Please provide your email address to receive an email when new articles are posted on . In early August, the FDA approved neffy epinephrine nasal spray to treat emergent type 1 allergic reactions in ...
EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European UnionARS Pharma’s partner, ...
An everyday hay fever spray may do more than tame sneezes. In a rigorously run German trial, adults who used azelastine nasal spray three times a day were less likely to catch COVID-19 than those who ...
The incidence of provider-diagnosed AR in the United States is approximately 60 million people, including both adults and children. 2 The incidence is even higher when patients self-report AR: between ...
The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the neffy epinephrine nasal spray. The product from ARS Pharmaceuticals, previously ...
Many consumers are familiar with EpiPens and other epinephrine injectables when treating severe allergic reactions. Now, the Food and Drug Administration (FDA) has approved the first non-injectable ...
On 9 August, US health officials approved the first nasal spray to treat allergic reactions from drugmaker ARS Pharmaceuticals Inc, an alternative to injectable allergy medications like EpiPen. The ...
Please provide your email address to receive an email when new articles are posted on . ARS Pharma recently announced that the FDA will likely rule on a new drug application for the company’s neffy ...
Whether you’re stuffed up from allergies or are dealing with the common cold, the best nasal decongestants help reduce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results